[go: up one dir, main page]

NO20020669L - Fenantrolin-7-on-derivater og deres terapeutiske anvendelser - Google Patents

Fenantrolin-7-on-derivater og deres terapeutiske anvendelser

Info

Publication number
NO20020669L
NO20020669L NO20020669A NO20020669A NO20020669L NO 20020669 L NO20020669 L NO 20020669L NO 20020669 A NO20020669 A NO 20020669A NO 20020669 A NO20020669 A NO 20020669A NO 20020669 L NO20020669 L NO 20020669L
Authority
NO
Norway
Prior art keywords
phenanthroline
derivatives
therapeutic applications
compounds
antitumoral
Prior art date
Application number
NO20020669A
Other languages
English (en)
Other versions
NO20020669D0 (no
Inventor
Evelyne Delfourne
Francis Darro
Jean Bastide
Robert Kiss
Armand Frydman
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of NO20020669D0 publication Critical patent/NO20020669D0/no
Publication of NO20020669L publication Critical patent/NO20020669L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20020669A 1999-08-13 2002-02-11 Fenantrolin-7-on-derivater og deres terapeutiske anvendelser NO20020669L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910493A FR2797446B1 (fr) 1999-08-13 1999-08-13 Derives de phenanthroline-7-ones et leurs applications en therapeutique
PCT/FR2000/002313 WO2001012632A2 (fr) 1999-08-13 2000-08-11 Derives de phenanthroline-7-ones et leurs applications en therapeutique

Publications (2)

Publication Number Publication Date
NO20020669D0 NO20020669D0 (no) 2002-02-11
NO20020669L true NO20020669L (no) 2002-04-15

Family

ID=9549146

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020669A NO20020669L (no) 1999-08-13 2002-02-11 Fenantrolin-7-on-derivater og deres terapeutiske anvendelser

Country Status (21)

Country Link
US (1) US6809096B1 (no)
EP (1) EP1202993B1 (no)
JP (1) JP2003526627A (no)
KR (1) KR20020056883A (no)
CN (1) CN1187352C (no)
AT (1) ATE307131T1 (no)
AU (1) AU777689B2 (no)
BR (1) BR0013239A (no)
CA (1) CA2381352A1 (no)
CZ (1) CZ2002529A3 (no)
DE (1) DE60023307D1 (no)
FR (1) FR2797446B1 (no)
HU (1) HUP0203033A3 (no)
IL (1) IL147901A0 (no)
MX (1) MXPA02001493A (no)
NO (1) NO20020669L (no)
NZ (1) NZ516944A (no)
PL (1) PL353454A1 (no)
SK (1) SK1672002A3 (no)
WO (1) WO2001012632A2 (no)
ZA (1) ZA200201003B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012006903B4 (de) * 2012-04-05 2016-06-30 Christian-Albrechts-Universität Zu Kiel Neue aromatische Heterocyclen, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend neue aromatische Heterocyclen
PL2984184T3 (pl) 2013-04-09 2021-06-14 The Board Of Trustees Of The University Of Illinois Stosowanie DNQ lub DNQ-87 w połączeniu z inhibitorem PARP1 do leczenia nowotworu
CN103254191B (zh) * 2013-05-17 2016-01-27 中国人民解放军第二军医大学 取代芳香四环类抗真菌化合物及其制备方法与应用
CN116082332B (zh) * 2022-12-14 2024-12-24 爱斯特（成都）生物制药股份有限公司 一种制备2-苯甲酰基-1,10-菲罗啉的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182287A (en) * 1989-11-03 1993-01-26 Harbor Branch Oceanographic Bioactive heterocycle alkaloids and methods of use

Also Published As

Publication number Publication date
NZ516944A (en) 2004-07-30
HUP0203033A2 (hu) 2003-01-28
US6809096B1 (en) 2004-10-26
WO2001012632A2 (fr) 2001-02-22
EP1202993A2 (fr) 2002-05-08
SK1672002A3 (en) 2002-10-08
MXPA02001493A (es) 2002-07-02
PL353454A1 (en) 2003-11-17
EP1202993B1 (fr) 2005-10-19
JP2003526627A (ja) 2003-09-09
ATE307131T1 (de) 2005-11-15
BR0013239A (pt) 2002-04-23
KR20020056883A (ko) 2002-07-10
ZA200201003B (en) 2003-10-29
NO20020669D0 (no) 2002-02-11
CN1187352C (zh) 2005-02-02
CA2381352A1 (fr) 2001-02-22
WO2001012632A3 (fr) 2001-07-19
CZ2002529A3 (cs) 2002-05-15
CN1373761A (zh) 2002-10-09
FR2797446A1 (fr) 2001-02-16
IL147901A0 (en) 2002-08-14
HUP0203033A3 (en) 2003-12-29
DE60023307D1 (de) 2006-03-02
AU7012500A (en) 2001-03-13
FR2797446B1 (fr) 2001-11-02
AU777689B2 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
GEP20063799B (en) Tropane derivatives useful in therapy
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GEP20053673B (en) Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
BR0313555A (pt) Aplicação de inibidores de ikb-cinase na terapia da dor
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
GB0114286D0 (en) Nucleoside Derivatives
BR0108395A (pt) Derivados de pirrolopirimidinona, processos de preparação e uso
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
SE0302116D0 (sv) Novel compounds
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MY139676A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
SE0302572D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20020669L (no) Fenantrolin-7-on-derivater og deres terapeutiske anvendelser
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
PT1292303E (pt) Formulacao farmaceutica estavel compreendendo modificacao de torsemida ii
SE0004827D0 (sv) Therapeutic compounds
NO20020668L (no) Ascidideminderivater og deres terapeutiske anvendelser
AR029415A1 (es) Pirroles sustituidos, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos compuestos para la preparacion de medicamentos
BR0009113A (pt) Composição farmacêutica à base de compostospoliaromáticos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application